- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05685056
Nutrition & Food Choices in Early Pregnancy (PICk)
Nutrition and Food Choices in Early Pregnancy - a Nutrition Education Intervention
Study Overview
Detailed Description
Iodine is important for the synthesis of thyroid hormones, which are driving normal brain development in fetal and postnatal life.
The required level of iodine intake is 140μg/day and there is not proposed increment for pregnant women from the United Kingdom (UK) Department of Health, in contrast to the World Health Organisation (WHO), EFSA, US Institute of Medicine (IoM) and SANZ, that propose an intake in pregnancy which varies from 200 to 150μg/day. In the UK, based on our previous findings, 60% of women in pregnancy do not meet the 250μg/day WHO recommendation of intake.
Over half mothers and practitioners in the UK were found to be unable to identify correct sources of iodine. However, most women have reported willingness to modify dietary behaviour if they received information related to the importance of iodine in pregnancy.
This intervention focuses on providing information about iodine and its importance in pregnancy that would potentially help women improve their iodine status. The intervention was designed with participants involvement and their views on best way of getting information, informed by in-depth qualitative work.
The hypothesis is that increasing knowledge and awareness about the importance, sources and requirements of iodine during pregnancy will lead to change in practice and increased iodine intake.
Methods:
The study is a randomised controlled trial that lasts for 12 weeks. Women in preconception and in the 1st pregnancy trimester will be recruited and will be randomised either to the control or to the intervention group.
The study involves 3 meeting with the participants, at baseline and after 6 and 12 weeks. For women who try to conceive, if conception occurs within the study period, there is a fourth (optional) meeting in the 12th week of pregnancy.
Participants are informed about the study without getting details of the aim (to increase the iodine status of those in the treatment group). This is in order to decrease any bias and avoid leading participants to self-research the topic of iodine nutrition. Women of both study arms receive standard care and the study will not aim to change this. The treatment group is to receive 1-2 weekly text messages focusing on iodine-rich foods importance, barriers identification and tips with ways to include them in the diet.
Samples collection and analysis:
- Questionnaires (demographic, dietary, knowledge, awareness and intervention assessment questionnaires) will be completed by the participants at the place of recruitment / meeting with the researcher after full instructions by the researcher in visits 1, 2 and 3 (and optional visit 4).
- Participants will be given 12 pots for spot urine samples collection in each visit. They will be asked to collect 10 urine samples over 3-4 days. Urinary iodine and creatinine concentrations will be measured.
- A finger prick dried blood spot sample will be taken from each participant in each visit by the researcher. Thyroglobulin will be measured.
Power calculation:
The primary aim of the study is to decrease the proportion of women not meeting the recommended intake for iodine.
Based on a proportion of 60% of women currently not meeting the 250 μg/day recommended intake 5, a sample size of N=84 in total (42 per group) would allow to detect a decrease in proportion down to 30%. This is achievable based on the % of women with an intake of 150-249 μg/day, who could increase consumption by 100 μg/day (equivalent to a 200ml portion of milk and a 125g portion of yoghurt per day) and therefore meet the threshold. Adjusting for 15% dropout, a sample of 50 per group would be sufficient.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Glasgow, United Kingdom
- Community
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Trying to conceive or first trimester pregnant women
- English speaking
- Healthy
Exclusion Criteria:
- Abnormal pregnancies
- Known thyroid disorders, renal disease, multiple pregnancies, development of gestational diabetes
- Participation in another trial
- Not owning a mobile phone
- Followed by a dietitian at the time of the trial
- Existing or past eating disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The control group will receive no intervention, and will be receiving only text reminders regarding the study, the following visits and study logistics in order to limit dropout rate.
|
|
|
Experimental: Intervention group
Intervention will happen with weekly text messages during the study period, focusing on pregnancy nutrition and iodine rich foods.
The texts will be based on the taxonomy of behavior change techniques used in interventions, the nudge theory and will be covering themes identified on our previous research.
|
Texts with detailed information focusing on nutrition and iodine rich foods specifically, every 3-5 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
proportion of women not meeting the recommended intake for iodine
Time Frame: 6 weeks
|
measured by validated food frequency questionnaire
|
6 weeks
|
|
proportion of women not meeting the recommended intake for iodine
Time Frame: 12 weeks
|
measured by validated food frequency questionnaire
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
iodine awareness
Time Frame: 6 weeks
|
Measured by questionnaire, as a median score
|
6 weeks
|
|
iodine awareness
Time Frame: 12 weeks
|
Measured by questionnaire, as a median score
|
12 weeks
|
|
Iodine knowledge
Time Frame: 6 weeks
|
Measured by questionnaires, as a median score
|
6 weeks
|
|
Iodine knowledge
Time Frame: 12 weeks
|
Measured by questionnaires, as a median score
|
12 weeks
|
|
Thyroglobulin concentration
Time Frame: 6 weeks
|
measured by immunoassay
|
6 weeks
|
|
Thyroglobulin concentration
Time Frame: 12 weeks
|
measured by immunoassay
|
12 weeks
|
|
Change in urinary iodine concentration (from baseline)
Time Frame: 6 weeks
|
measured by colorimetry
|
6 weeks
|
|
Change in urinary iodine concentration (from baseline)
Time Frame: 12 weeks
|
measured by colorimetry
|
12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 200160090
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iodine Deficiency
-
DTU National Food InstituteUniversity Hospital Bispebjerg and FrederiksbergRecruitingDiet Habit | Iodine Deficiency | Iodine ToxicityDenmark
-
Universidade do PortoHospital de Braga; NOVA Medical School; Centro Hospitalar De São João, E.P.E.; Centro... and other collaboratorsCompletedIodine Deficiency | Iodine Status in PregnancyPortugal
-
Mahidol UniversityCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyUniversity of Zagreb; Global Alliance for Improved Nutrition; UNICEF; St. Luke's... and other collaboratorsCompletedIodine DeficiencyPhilippines, Switzerland, China, Croatia
-
EUthyroidUK Research and Innovation; EU HorizonRecruitingIodine DeficiencyBangladesh, Norway, Pakistan, Poland, United Kingdom
-
Swiss Federal Institute of TechnologyUNICEF; Pan American Health OrganizationCompletedIodine DeficiencyAntigua and Barbuda, Barbados, Belize, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago
-
Swiss Federal Institute of TechnologyCompletedIodine DeficiencyMorocco
-
qingya tangCompletedPregnancy | Iodine DeficiencyChina
-
EUthyroidUK Research and Innovation; EU HorizonRecruitingIodine DeficiencySlovenia, Germany, Bangladesh, Cyprus, Pakistan, United Kingdom
Clinical Trials on Text messages
-
Friedrich-Alexander-Universität Erlangen-NürnbergPhilipps University Marburg Medical CenterCompleted
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
Children's Hospitals and Clinics of MinnesotaHealthPartners InstituteUnknownAsthmaUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedSmoking | PregnancyUnited States
-
Medical University of South CarolinaRoswell Park Cancer InstituteCompleted
-
Auburn UniversityCompleted
-
Centre for Addiction and Mental HealthHealth CanadaCompleted
-
Vanderbilt University Medical CenterCompleted
-
Imperial College LondonBarts & The London NHS Trust; Mid and South Essex NHS Foundation Trust; Royal... and other collaboratorsCompleted
-
University of ManchesterNorthern Care Alliance NHS Foundation Trust; University of Oxford; Manchester...Completed